Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-26-036914
Filing Date
2026-05-20
Accepted
2026-05-20 16:23:39
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B5 merck-prospectussupplement.htm 424B5 706171
2 merckexfilingfees051926.htm   iXBRL EX-FILING FEES 45967
3 descriptionofthenotes1a.jpg GRAPHIC 12035
4 logo1a.jpg GRAPHIC 11105
  Complete submission text file 0001628280-26-036914.txt   941604

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT merckexfilingfees051926_htm.xml XML 13396
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278066 | Film No.: 261004351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)